Actively executing its growth-by-acquisition strategy, building a portfolio of clinically proven, naturally formulated supplements The BergaMet NA brand is well-positioned for growth throughout North America with its proprietary 47% BPF formulations developed for cardiovascular health, women’s health, immune support, sports performance and recovery UBN subsidiary, with its KETONOMICS(R) proprietary formulation, is well-aligned with Grey Cloak’s […]

PACR bought nine parcels comprising 250 acres of land in Fraser Valley, British Columbia Share purchase agreement worth $1.5 million cash plus 3 million common shares PACR leverages genetic technology to produce high-yield cannabinoid-specific cultivars that thrive in B.C. climate Pac Roots Cannabis (CSE: PACR), an innovative genetics-based cannabis company based in Canada, has just […]

BudCars CEO featured guest during “Cannabis Talk 101” show SGMD partnership allowed company to “focus on growth” Walker recognizes Sugarmade’s great accounting, management team The history and future of BudCars Cannabis Delivery Service was spotlighted during a recent “Cannabis Talk 101” episode. BudCars founder and CEO Clinton Walker was a featured guest on the global […]

Q3 2020 revenue numbers paint a bright future for KAVL with revenue up by approximately 44% Company closely focused on expanding distribution into large national retailers, convenience chains during Q4 Much of Q3 activity centered around Bidi(TM) Sticks Kaival Brands Innovations Group (OTCQB: KAVL), a company focused on growing and incubating innovative and profitable products […]

Following $1.25 million donation, UC Berkeley launching Center for the Science of Psychedelics Pure Extract Technologies Inc. expanding into functional and medicinal mushroom market Psychedelic compounds increasingly being studied to treat wide range of physical, mental conditions Pure Extracts plans to obtain a Natural Health Products Site License from Health Canada to buy, sell, functional […]

Predictive Oncology develops AI-solutions designed to assist clinicians in formulating personalized treatment plans for oncological patients Artificial Intelligence is being increasingly used to help understand and accurately predict how drug therapies can interact with specific patients POAI’s TumorGenesis subsidiary is also creating laboratory-grown tumors to help clinicians and researchers to better test therapies Predictive Oncology […]

Pivotal Phase 2 Berubicin trial expected to commence in Q1 2021 following planned IND submission in Q4 2020 CNS Pharmaceuticals also plans to begin pre-clinical work on Berubicin in connection with treatment for lymphomas, pancreatic, and ovarian cancers Brain tumor drug therapeutics market expected to reach $3.4 billion by 2025 CNS Pharmaceuticals (NASDAQ: CNSP), a […]

SRAX recently closed acquisition of LD Micro, leading micro-cap information portal LD Micro to become wholly-owned subsidiary of SRAX for 1.6 million in common stock plus $4 million cash Acquisition to accelerate adoption of Sequire, SRAX’s SaaS investment analytics platform Sequire revenue grew 29% year-over-year for Q2 2020, user base doubled to one million users […]

Partnership allows space for significant exposure, growth over critical launch period AffPapa’s dedication to mission provides opportunities to broaden operator base, offer best services Mobius has already entered iGaming, eSports sectors with three differentiated brand offerings and hundreds of joint ventures with VIP and Master gaming affiliates Mobius Interactive has announced a new partnership with AffPapa, […]

Company awarded government grant that could total $1.45 million to develop design for production of rare earth elements UUUU excited to play role in effort to develop domestic sources of rare earth production Energy Fuels announced entry into REE sector earlier this year, ideal complement to company’s other rare earth initiatives Energy Fuels (TSX: EFR) […]